Cargando…
Poldip2 mediates blood‐brain barrier disruption and cerebral edema by inducing AQP4 polarity loss in mouse bacterial meningitis model
BACKGROUND: Specific highly polarized aquaporin‐4 (AQP4) expression is reported to play a crucial role in blood‐brain barrier (BBB) integrity and brain water transport balance. The upregulation of polymerase δ‐interacting protein 2 (Poldip2) was involved in aggravating BBB disruption following ische...
Autores principales: | , , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7702237/ https://www.ncbi.nlm.nih.gov/pubmed/32790044 http://dx.doi.org/10.1111/cns.13446 |
_version_ | 1783616573486923776 |
---|---|
author | Gao, Meng Lu, Weitian Shu, Yue Yang, Zhengyu Sun, Shanquan Xu, Jin Gan, Shengwei Zhu, Shujuan Qiu, Guoping Zhuo, Fei Xu, Shiye Wang, Yiying Chen, Junhong Wu, Xuan Huang, Juan |
author_facet | Gao, Meng Lu, Weitian Shu, Yue Yang, Zhengyu Sun, Shanquan Xu, Jin Gan, Shengwei Zhu, Shujuan Qiu, Guoping Zhuo, Fei Xu, Shiye Wang, Yiying Chen, Junhong Wu, Xuan Huang, Juan |
author_sort | Gao, Meng |
collection | PubMed |
description | BACKGROUND: Specific highly polarized aquaporin‐4 (AQP4) expression is reported to play a crucial role in blood‐brain barrier (BBB) integrity and brain water transport balance. The upregulation of polymerase δ‐interacting protein 2 (Poldip2) was involved in aggravating BBB disruption following ischemic stroke. This study aimed to investigate whether Poldip2‐mediated BBB disruption and cerebral edema formation in mouse bacterial meningitis (BM) model occur via induction of AQP4 polarity loss. METHODS AND RESULTS: Mouse BM model was induced by injecting mice with group B hemolytic streptococci via posterior cistern. Recombinant human Poldip2 (rh‐Poldip2) was administered intranasally at 1 hour after BM induction. Small interfering ribonucleic acid (siRNA) targeting Poldip2 was administered by intracerebroventricular (i.c.v) injection at 48 hours before BM induction. A specific inhibitor of matrix metalloproteinases (MMPs), UK383367, was administered intravenously at 0.5 hour before BM induction. Western blotting, immunofluorescence staining, quantitative real‐time PCR, neurobehavioral test, brain water content test, Evans blue (EB) permeability assay, transmission electron microscopy (TEM), and gelatin zymography were carried out. The results showed that Poldip2 was upregulated and AQP4 polarity was lost in mouse BM model. Both Poldip2 siRNA and UK383367 improved neurobehavioral outcomes, alleviated brain edema, preserved the integrity of BBB, and relieved the loss of AQP4 polarity in BM model. Rh‐Poldip2 upregulated the expression of MMPs and glial fibrillary acidic protein (GFAP) and downregulated the expression of β‐dystroglycan (β‐DG), zonula occludens‐1 (ZO‐1), occludin, and claudin‐5; whereas Poldip2 siRNA downregulated the expression of MMPs and GFAP, and upregulated β‐DG, ZO‐1, occludin, and claudin‐5. Similarly, UK383367 downregulated the expression of GFAP and upregulated the expression of β‐DG, ZO‐1, occludin, and claudin‐5. CONCLUSION: Poldip2 inhibition alleviated brain edema and preserved the integrity of BBB partially by relieving the loss of AQP4 polarity via MMPs/β‐DG pathway. |
format | Online Article Text |
id | pubmed-7702237 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | John Wiley and Sons Inc. |
record_format | MEDLINE/PubMed |
spelling | pubmed-77022372020-12-03 Poldip2 mediates blood‐brain barrier disruption and cerebral edema by inducing AQP4 polarity loss in mouse bacterial meningitis model Gao, Meng Lu, Weitian Shu, Yue Yang, Zhengyu Sun, Shanquan Xu, Jin Gan, Shengwei Zhu, Shujuan Qiu, Guoping Zhuo, Fei Xu, Shiye Wang, Yiying Chen, Junhong Wu, Xuan Huang, Juan CNS Neurosci Ther Original Articles BACKGROUND: Specific highly polarized aquaporin‐4 (AQP4) expression is reported to play a crucial role in blood‐brain barrier (BBB) integrity and brain water transport balance. The upregulation of polymerase δ‐interacting protein 2 (Poldip2) was involved in aggravating BBB disruption following ischemic stroke. This study aimed to investigate whether Poldip2‐mediated BBB disruption and cerebral edema formation in mouse bacterial meningitis (BM) model occur via induction of AQP4 polarity loss. METHODS AND RESULTS: Mouse BM model was induced by injecting mice with group B hemolytic streptococci via posterior cistern. Recombinant human Poldip2 (rh‐Poldip2) was administered intranasally at 1 hour after BM induction. Small interfering ribonucleic acid (siRNA) targeting Poldip2 was administered by intracerebroventricular (i.c.v) injection at 48 hours before BM induction. A specific inhibitor of matrix metalloproteinases (MMPs), UK383367, was administered intravenously at 0.5 hour before BM induction. Western blotting, immunofluorescence staining, quantitative real‐time PCR, neurobehavioral test, brain water content test, Evans blue (EB) permeability assay, transmission electron microscopy (TEM), and gelatin zymography were carried out. The results showed that Poldip2 was upregulated and AQP4 polarity was lost in mouse BM model. Both Poldip2 siRNA and UK383367 improved neurobehavioral outcomes, alleviated brain edema, preserved the integrity of BBB, and relieved the loss of AQP4 polarity in BM model. Rh‐Poldip2 upregulated the expression of MMPs and glial fibrillary acidic protein (GFAP) and downregulated the expression of β‐dystroglycan (β‐DG), zonula occludens‐1 (ZO‐1), occludin, and claudin‐5; whereas Poldip2 siRNA downregulated the expression of MMPs and GFAP, and upregulated β‐DG, ZO‐1, occludin, and claudin‐5. Similarly, UK383367 downregulated the expression of GFAP and upregulated the expression of β‐DG, ZO‐1, occludin, and claudin‐5. CONCLUSION: Poldip2 inhibition alleviated brain edema and preserved the integrity of BBB partially by relieving the loss of AQP4 polarity via MMPs/β‐DG pathway. John Wiley and Sons Inc. 2020-08-12 /pmc/articles/PMC7702237/ /pubmed/32790044 http://dx.doi.org/10.1111/cns.13446 Text en © 2020 The Authors. CNS Neuroscience & Therapeutics published by John Wiley & Sons Ltd This is an open access article under the terms of the http://creativecommons.org/licenses/by/4.0/ License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Original Articles Gao, Meng Lu, Weitian Shu, Yue Yang, Zhengyu Sun, Shanquan Xu, Jin Gan, Shengwei Zhu, Shujuan Qiu, Guoping Zhuo, Fei Xu, Shiye Wang, Yiying Chen, Junhong Wu, Xuan Huang, Juan Poldip2 mediates blood‐brain barrier disruption and cerebral edema by inducing AQP4 polarity loss in mouse bacterial meningitis model |
title | Poldip2 mediates blood‐brain barrier disruption and cerebral edema by inducing AQP4 polarity loss in mouse bacterial meningitis model |
title_full | Poldip2 mediates blood‐brain barrier disruption and cerebral edema by inducing AQP4 polarity loss in mouse bacterial meningitis model |
title_fullStr | Poldip2 mediates blood‐brain barrier disruption and cerebral edema by inducing AQP4 polarity loss in mouse bacterial meningitis model |
title_full_unstemmed | Poldip2 mediates blood‐brain barrier disruption and cerebral edema by inducing AQP4 polarity loss in mouse bacterial meningitis model |
title_short | Poldip2 mediates blood‐brain barrier disruption and cerebral edema by inducing AQP4 polarity loss in mouse bacterial meningitis model |
title_sort | poldip2 mediates blood‐brain barrier disruption and cerebral edema by inducing aqp4 polarity loss in mouse bacterial meningitis model |
topic | Original Articles |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7702237/ https://www.ncbi.nlm.nih.gov/pubmed/32790044 http://dx.doi.org/10.1111/cns.13446 |
work_keys_str_mv | AT gaomeng poldip2mediatesbloodbrainbarrierdisruptionandcerebraledemabyinducingaqp4polaritylossinmousebacterialmeningitismodel AT luweitian poldip2mediatesbloodbrainbarrierdisruptionandcerebraledemabyinducingaqp4polaritylossinmousebacterialmeningitismodel AT shuyue poldip2mediatesbloodbrainbarrierdisruptionandcerebraledemabyinducingaqp4polaritylossinmousebacterialmeningitismodel AT yangzhengyu poldip2mediatesbloodbrainbarrierdisruptionandcerebraledemabyinducingaqp4polaritylossinmousebacterialmeningitismodel AT sunshanquan poldip2mediatesbloodbrainbarrierdisruptionandcerebraledemabyinducingaqp4polaritylossinmousebacterialmeningitismodel AT xujin poldip2mediatesbloodbrainbarrierdisruptionandcerebraledemabyinducingaqp4polaritylossinmousebacterialmeningitismodel AT ganshengwei poldip2mediatesbloodbrainbarrierdisruptionandcerebraledemabyinducingaqp4polaritylossinmousebacterialmeningitismodel AT zhushujuan poldip2mediatesbloodbrainbarrierdisruptionandcerebraledemabyinducingaqp4polaritylossinmousebacterialmeningitismodel AT qiuguoping poldip2mediatesbloodbrainbarrierdisruptionandcerebraledemabyinducingaqp4polaritylossinmousebacterialmeningitismodel AT zhuofei poldip2mediatesbloodbrainbarrierdisruptionandcerebraledemabyinducingaqp4polaritylossinmousebacterialmeningitismodel AT xushiye poldip2mediatesbloodbrainbarrierdisruptionandcerebraledemabyinducingaqp4polaritylossinmousebacterialmeningitismodel AT wangyiying poldip2mediatesbloodbrainbarrierdisruptionandcerebraledemabyinducingaqp4polaritylossinmousebacterialmeningitismodel AT chenjunhong poldip2mediatesbloodbrainbarrierdisruptionandcerebraledemabyinducingaqp4polaritylossinmousebacterialmeningitismodel AT wuxuan poldip2mediatesbloodbrainbarrierdisruptionandcerebraledemabyinducingaqp4polaritylossinmousebacterialmeningitismodel AT huangjuan poldip2mediatesbloodbrainbarrierdisruptionandcerebraledemabyinducingaqp4polaritylossinmousebacterialmeningitismodel |